Roivant Sciences (ROIV) Current Assets (2021 - 2026)

Roivant Sciences' Current Assets history runs 6 years deep, the most recent figure standing at $5.2 billion for Q1 2026.

• Quarterly Current Assets rose 3.35% year-over-year to $5.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 billion (up 3.35% YoY) and the FY2026 annual result came in at $5.2 billion, up 3.35% from the prior year.
• Current Assets was $5.2 billion for Q1 2026 at Roivant Sciences, up from $461.5 million in the prior quarter.
• Across five years, Current Assets topped out at $6.7 billion in Q1 2024 and bottomed at $461.5 million in Q4 2025.
• A 5-year average of $3.1 billion and a median of $2.0 billion in 2022 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2023 — Current Assets slumped 61.39% — and 2024, when it soared 284.43%.
• Roivant Sciences' Current Assets stood at $1.6 billion in 2022, then plunged by 61.39% to $635.7 million in 2023, then gained by 3.33% to $656.8 million in 2024, then decreased by 29.74% to $461.5 million in 2025, then surged by 1019.79% to $5.2 billion in 2026.
• Business Quant data shows ROIV's Current Assets at $5.2 billion in Q1 2026, $461.5 million in Q4 2025, and $4.5 billion in Q3 2025.